SCHEMBL3530476

SCHEMBL3530476

NC1CC(C(=O)O)Oc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 4/20 0.41
CYP2C9 P11712 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
GRM2 Q14416 2/20 0.38
GRM3 Q14832 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
KMT2A Q03164 1/20 0.38
GRM8 O00222 1/20 0.38
GRM5 P41594 1/20 0.38
GRM1 Q13255 1/20 0.38
GRM7 Q14831 1/20 0.38
GRM4 Q14833 1/20 0.38
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A3 Q01959 1/20 0.37
SIRT2 Q8IXJ6 2/20 0.36
ABCB1 P08183 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24496706 0.81 SMN1; SMN2 (0.39) SIRT1CYP2C9ATMSMN1; SMN2GRM2
SCHEMBL6327386 0.81 SMN1; SMN2 (0.39) SIRT1CYP2C9ATMSMN1; SMN2GRM2
SCHEMBL27014131 0.81 SMN1; SMN2 (0.39) SIRT1CYP2C9ATMSMN1; SMN2GRM2
SCHEMBL27014130 0.81 SMN1; SMN2 (0.39) SIRT1CYP2C9ATMSMN1; SMN2GRM2
SCHEMBL3355152 0.78 ALDH1A1 (0.43) ATMMEN1CYP1A2KMT2AHPGD
SCHEMBL27818783 0.78 SMN1; SMN2 (0.36) SIRT1CYP2C9ATMSMN1; SMN2GRM2
Hydrochloric Acid SCHEMBL25390853 0.77 ALDH1A1 (0.42) ATMMEN1CYP1A2KMT2AHPGD
SCHEMBL7057869 0.76 PPARG (0.40) SIRT1SMN1; SMN2GRM2GRM3MEN1
SCHEMBL1980720 0.75 MAOB (0.41) CYP2C9ATMSLC6A2SLC6A3NISCH
SCHEMBL7976360 0.73 CYP2C9 (0.39) CYP2C9ATMGRM2GRM3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834010-B2 Modulators of peripheral 5-HT receptors SERODUS AS (NO) 2010-11-16 US disclosed
US-20070254874-A1 Modulators of Preripheral 5-Ht Receptors BIO-MEDISINSK INNOVASJON (NO) 2007-11-01 US disclosed
EP-1701951-A2 MODULATORS OF PERIPHERAL 5-HT RECEPTORS Bio-Medisinsk Innovasjon AS (NO) 2006-09-20 EP disclosed
WO-2005061483-A2 MODULATORS OF PERIPHERAL 5-HT RECEPTORS BIO-MEDISINSK INNOVASJON AS (NO) 2005-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254874-A1 Modulators of Preripheral 5-Ht Receptors HTR4, HTR5A, HTR6 SIRT1 3992/4885CYP2C9 1277/4885ATM 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.